Filtered By:
Nutrition: Vitamins

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 43792 results found since Jan 2013.

Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis Patients.
Abstract Warfarin inhibits vitamin-K dependent proteins involved in bone mineralization and the prevention of vascular calcification (bone Gla protein BGP, matrix Gla protein MGP). In this multicenter, cross-sectional study with 3-year follow-up, data from 387 patients on hemodialysis for ≥1 year at 18 dialysis units were analyzed. Patients on warfarin treatment for > 1 year (11.9% of the population) were compared with the remaining cohort for vertebral fractures, vascular calcifications and mortality. Vertebral fractures and vascular calcifications were sought in L-L vertebral X-rays (D4 to L5). Compared wit...
Source: Current Vascular Pharmacology - August 1, 2013 Category: Drugs & Pharmacology Authors: Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M, The Vertebral Fractures And Vascular Calcifications Study Group Tags: Curr Vasc Pharmacol Source Type: research

Increased Peripheral Arterial Calcification in Patients Receiving Warfarin Vascular Medicine
Conclusions Warfarin use is associated with lower extremity arterial calcification in both men and women independent of age, sex, diabetes status, and other patient characteristics. This may have implications for the choice of therapies for long-term anticoagulation.
Source: JAHA:Journal of the American Heart Association - January 25, 2016 Category: Cardiology Authors: Han, K. H., O'Neill, W. C. Tags: Peripheral Vascular Disease, Vascular Disease Vascular Medicine Source Type: research

A comprehensive approach to complementary and alternative medicine usage among patients from a vascular department
CONCLUSIONS: CAM use is frequent and perceived as safe and beneficial among VS outpatients; nonetheless, patients do not disclose CAM use with their primary vascular surgeons, and a wide range of reasons are given by the patients that prevent effective and open communication.PMID:33853457 | DOI:10.1177/17085381211006595
Source: Vascular - April 15, 2021 Category: Surgery Authors: Cesar Cuen-Ojeda Carlos A Hinojosa Iraz ú Contreras-Yáñez Erika Elenes-S ánchez Casandra Rosas-R íos Miguel A M éndez-Sosa Angel Ballinas-S ánchez Virginia Pascual-Ramos Source Type: research

The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF- κB signaling
This study aimed to investigate the potential role of SCFAs in vascular calcification. Using cellular and animal models of vascular calcification, we showed that butyrate significantly enhanced high phosphate (Pi)-induced calcification and osteogenic transition of vascular smooth muscle cells (VSMC) in vitro, whereas acetate and propionate had no effects. Subsequent studies confirmed that butyrate significantly promoted high Pi-induced aortic ring calcification ex vivo and high dose vitamin D3 (vD3)-induced mouse vascular calcification in vivo. Mechanistically, butyrate significantly inhibited histone deacetylase (HDAC) ex...
Source: Vascular Pharmacology - August 11, 2022 Category: Drugs & Pharmacology Authors: Hui Zhong Hongjiao Yu Jiaxin Chen Simon Wing Fai Mok Xiao Tan Bohou Zhao Shengping He Lan Lan Xiaodong Fu Guojun Chen Dongxing Zhu Source Type: research

Ameliorative effect of allicin on vascular calcification via inhibiting endoplasmic reticulum stress
CONCLUSIONS: Allicin could ameliorate aortic VC and stiffness. The ameliorative effect of allicin on VC might be mediated by inhibiting PERK/eIF2α/ATF4 cascades. Our results might provide a new proof for VC treatment.PMID:34301159 | DOI:10.1177/17085381211035291
Source: Vascular - July 24, 2021 Category: Surgery Authors: Qin Wang Ping Lin Li Feng Qian Ren Xiaofeng Xie Bin Zhang Source Type: research

Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a
CONCLUSIONS: Our study provides evidence proving that inhibition of local VDR signaling in VSMCs could prevent VC in CKD and indicates a possible role for miR-145a in this process.PMID:37381989 | DOI:10.1161/ATVBAHA.122.318834
Source: Arteriosclerosis, Thrombosis and Vascular Biology - June 29, 2023 Category: Cardiology Authors: Maite Caus Cristina Alonso-Montes Jose Luis Fernandez-Martin Manuel Marti-Antonio Milica Bozic Jose M Valdivielso Source Type: research